Clinical Trial Update: An Open Label Study of a Peptide Vaccine in Patients With Stage III Colon Cancer [Phase 1]

View source ↗

Summary

An open-label Phase 1 trial evaluated a peptide vaccine in patients with stage III colorectal cancer (colon cancer); the study status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• peptide vaccine

Snippet

Sponsor: Epimmune | Conditions: Colonic Neoplasms, Colorectal Neoplasms | Phase 1 | Status: COMPLETED